Morrison & Foerster LLP has been publishing a quarterly report since last year that looks at deals in the biotech industry, but for the first time in March the law firm added a new element – looking at biotech deals on a regional basis. With this, the law firm analyzed the number of innovating companies that, in 2013, developed and licensed products.
Image: Courtesy of Morrison & Foerster Morrison & Foerster's Stephen Thau says Boston lags other regions on the number of deals done by innovator companies.
